Posttranslational modifications induce autoantibodies with risk prediction capability in patients with small cell lung cancer.
Lastwika KJ, Kunihiro A, Solan JL, Zhang Y, Taverne LR, Shelley D, Rho JH, Randolph TW, Li CI, Grogan EL, Massion PP, Fitzpatrick AL, MacPherson D, Houghton AM, Lampe PD.
Lastwika KJ, et al.
Sci Transl Med. 2023 Jan 11;15(678):eadd8469. doi: 10.1126/scitranslmed.add8469. Epub 2023 Jan 11.
Sci Transl Med. 2023.
PMID: 36630482
Free PMC article.